BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25378579)

  • 21. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
    Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
    Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.
    Troy SB; Musingwini G; Halpern MS; Huang C; Stranix-Chibanda L; Kouiavskaia D; Shetty AK; Chumakov K; Nathoo K; Maldonado YA
    J Infect Dis; 2013 Aug; 208(4):672-8. PubMed ID: 23661792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine.
    Martinez CV; Old MO; Kwock DK; Khan SS; Garcia JJ; Chan CS; Webster R; Falkovitz-Halpern MS; Maldonado YA
    J Infect Dis; 2004 Jul; 190(2):409-16. PubMed ID: 15216480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of culture, single and multiplex real-time PCR for detection of Sabin poliovirus shedding in recently vaccinated Indian children.
    Giri S; Rajan AK; Kumar N; Dhanapal P; Venkatesan J; Iturriza-Gomara M; Taniuchi M; John J; Abraham AM; Kang G
    J Med Virol; 2017 Aug; 89(8):1485-1488. PubMed ID: 28213965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination.
    Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Bruce Aylward R
    J Infect Dis; 2010 May; 201(10):1535-43. PubMed ID: 20367459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccinees by a sensitive reverse transcription-PCR method.
    Buonagurio DA; Coleman JW; Patibandla SA; Prabhakar BS; Tatem JM
    J Clin Microbiol; 1999 Feb; 37(2):283-9. PubMed ID: 9889205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
    Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW
    J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
    Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
    Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OPV Vaccination and Shedding Patterns in Mexican and US Children.
    Altamirano J; Sarnquist C; Behl R; García-García L; Ferreyra-Reyes L; Leary S; Maldonado Y
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S85-S89. PubMed ID: 30376085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks.
    Troy SB; Ferreyra-Reyes L; Huang C; Sarnquist C; Canizales-Quintero S; Nelson C; Báez-Saldaña R; Holubar M; Ferreira-Guerrero E; García-García L; Maldonado YA
    J Infect Dis; 2014 Jun; 209(11):1693-9. PubMed ID: 24367038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.
    Galal NM; Meshaal S; ElHawary R; Nasr E; Bassiouni L; Ashghar H; Farag NH; Mach O; Burns C; Iber J; Chen Q; ElMarsafy A
    BMC Res Notes; 2018 Oct; 11(1):717. PubMed ID: 30305145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay.
    Gnanashanmugam D; Falkovitz-Halpern MS; Dodge A; Fang M; Wong LJ; Esparza M; Hammon R; Rivas-Merelles EE; Santos JI; Maldonado Y
    J Clin Microbiol; 2007 Aug; 45(8):2419-25. PubMed ID: 17581940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.
    Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Aylward RB
    J Infect Dis; 2009 Sep; 200(5):794-801. PubMed ID: 19624278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the dynamics of oral poliovirus vaccine cessation.
    Thompson KM; Duintjer Tebbens RJ
    J Infect Dis; 2014 Nov; 210 Suppl 1():S475-84. PubMed ID: 25316870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells.
    Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M
    J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a multiplex RT-PCR assay for the identification of recombination types at different genomic regions of vaccine-derived polioviruses.
    Dimitriou TG; Kyriakopoulou Z; Tsakogiannis D; Fikatas A; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
    Virus Genes; 2016 Aug; 52(4):453-62. PubMed ID: 27098645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.